1 |
Martini L. 内分泌疾病百科全书——肾上腺皮质[M]. 北京: 科学出版社, 2008.
|
2 |
Grebe KG,Singh RJ. LC-MS/MS in the clinical laboratory – Where to from here?[J]. Clin Biochem Rev, 2011,32:5-31.
|
3 |
Ketha SS,Singh RJ,Ketha H. Role of mass spectrometry in clinical endocrinology[J]. Endocrinol Metab Clin, 2017,4:1-21.
|
4 |
中华医学会内分泌学分会肾上腺学组. 嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J]. 中华内分泌代谢杂志, 2016,32(3):181-187.
|
5 |
Eisenhofer G,Peitzsch M,Mcwhinney BC. Impact of LC-MS/MS on the laboratory diagnosis of catecholamine producing tumors[J]. Trends Anal Chem, 2016,84:106-116.
|
6 |
Eisenhofer G. Free or total metanephrines for diagnosis of pheochromocytoma: What is the difference?[J]. Clin Chem, 2001,47(6):988-989.
|
7 |
Weismann D,Peitzsch M,Raida A, et al. Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma[J]. Eur J Endocrinol, 2015,172(3):251-260.
|
8 |
Taylor RL,Singh RJ. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma[J]. Clin Chem, 2002,48:533-539.
|
9 |
Jong WHAD,Vries EGED,Wolffenbutte BHR, et al. Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction[J]. J Chromatogr B, 2010,878:1506-1512.
|
10 |
Jong WHAD,Graham KS,Van JDM, et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry[J]. Clin Chem, 2007,53(9):1684-1693.
|
11 |
Marney LC,Laha TJ,Baird GS, et al. Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography tandem mass spectrometry[J]. Clin Chem, 2008,54(10):1729-1932.
|
12 |
Woo HI,Yang JS,Oh HJ, et al. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography–tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis[J]. Clin Biochem, 2016,49(7-8):573-579.
|
13 |
Mirko P,Daniela P,Stephan G, et al. Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites[J]. Clin Chim Acta, 2013,418:50-58.
|
14 |
中华医学会内分泌学分会. 库欣综合征专家共识(2011年)[J]. 中华内分泌代谢杂志, 2012,28(2):96-102.
|
15 |
Filippo C,Mattia B,Marialuisa Z, et al. Screening tests for Cushing′s syndrome: urinary free cortisol role measured by LC-MS/MS[J]. J Clin Endocr Metab, 2015,100(10):3856-3861.
|
16 |
Wood L,Ducroq DH,Fraser HL, et al. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays[J]. Ann Clin Biochem, 2008,45:380-388.
|
17 |
Ifedayo AO,Olufemi AF. Urinary free cortisol in the diagnosis of Cushing′s syndrome: How useful?[J]. Niger J Clin Pract, 2013,16(3):269-272.
|
18 |
Gergely M,Zita T,Emese M, et al. Avalidated method for measurement of serum total, serum free, and salivary cortisol, using high-performance liquid chromatography coupled with high-resolution ESI-TOF mass spectrometry[J]. Anal Bioanal Chem, 2014,406:2333-2341.
|
19 |
Fong BMW,Tam S,Leung KSY. Improved liquid chromatography–tandem mass spectrometry method in clinical utility for the diagnosis of Cushing′s syndrome[J]. Anal Bioanal Chem, 2010,396:783-790.
|
20 |
Giorgia A,Andrea P,Carlo A, et al. Automated saliva processing for LC-MS/MS: Improving laboratory efficiency in cortisol and cortisone testing[J]. Clin Biochem, 2016,49:518-520.
|
21 |
中华医学会内分泌学分会肾上腺学组. 原发性醛固酮增多症诊断治疗的专家共识[J]. 中华内分泌代谢杂志, 2016,32(3):188-195.
|
22 |
Sealey JE. Plasma renin activity and plasma prorenin assays[J]. Clin Chem, 1991,37:1811-1819.
|
23 |
Manolopoulou J,Fischer E,Dietz A, et al. Clinical validation for the aldosterone-to-renin ratio and aldosteronesuppression testing using simultaneous fully automated chemiluminescence immunoassays[J]. J Hypert, 2015,33:2500-2511.
|
24 |
Campbell DJ,Nussberger J,Stowasser M, et al. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement[J]. Clin Chem, 2009,55:867-877.
|
25 |
Ahmed AH,Gordon RD,Taylor PJ, et al. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration[J].J Clin Endocr Metab, 2011,96:1797-1804.
|
26 |
Mayes D,Furuyama S,Kem DC, et al. A radioimmunoassay for plasma aldosterone[J]. J Clin Endocr Metab, 1970,30:682-685.
|
27 |
Pizzolo F,Corgnati A,Guarini P, et al. Plasma aldosterone assays: comparison between chemiluminescence-based and RIA methods[J]. Clin Chem, 2006,52:1431-1432.
|
28 |
Juutilainen A,Savolainen K,Romppanen J, et al. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism[J]. Clin Chim Acta, 2014,433:209-215.
|
29 |
Camenzind AG,van der Gugten JG,Popp R, et al. Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension[J]. Clin Proteom, 2013,10:20-28.
|
30 |
中华预防医学会出生缺陷预防与控制专业委员会新生儿筛查学组, 中国医师协会青春期医学专业委员会临床遗传学组, 中华医学会儿科学分会内分泌遗传代谢学组. 先天性肾上腺皮质增生症新生儿筛查共识[J]. 中国儿科杂志, 2016,54(6):404-409.
|
31 |
Marsden D,Larson CA. Emerging role for tandem mass spectrometry in detecting congenital adrenal hyperplasia[J]. Clin Chem, 2004,50(3):467-468.
|
32 |
Wudy SA,Hartmann M,Svoboda M. Determination of 17-hydroxyprogesterone in plasma by stable isotope dilution/benchtop liquid chromatography-tandem mass spectrometry[J]. Horm Res, 2000,53:68-71.
|
33 |
Baloeh Z,Carayon P,Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease[J]. Thyroid, 2003,13(1):3-126.
|
34 |
Stockigt J. Assessment of thyroid function: towards all integrated laboratory-clinical approach[J]. Clin Biochem Rev, 2003,24(4):109-122.
|
35 |
Surks MI,Ortiz E,Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management[J]. JAMA, 2004,291(2):228-238.
|
36 |
Col NFI,Surks MI,Daniels GH. Subclinical thyroid disease: clinical applications[J]. JAMA, 2004,291(2):239-243.
|
37 |
Demers LM,Spencer CA. Laboratory Medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease[J]. Clin Endocr (Oxf), 2003,58(2):138-140.
|
38 |
Ekins R. Measurement of free hormones in blood[J]. Endocr Rev, 1990,11(1):5-46.
|
39 |
Gounden V,Jonklaas J,Soldin SJ. A pilot study:subclinical hypothyroidism and free thyroid hormonemeasurement by immunoassay and mass spectrometry[J]. Clin Chim Acta, 2014,430: 121-124.
|
40 |
Van Houcke SK,Shimizu E, et al. IFCC international conventional reference procedure for the measurement of free thyroxine in serum[J]. Clin Chem Lab Med, 2011,49(8):1275-1281.
|
41 |
Soldin OP,Soldin SJ. Thyroid hormone testing by tandem mass spectrometry[J]. Clin Biochem, 2011,44:89-94.
|
42 |
Van Deventer HE,Soldin SJ. The expanding role of tandem mass spectrometry in optimizingdiagnosis and treatment of thyroid disease[J]. Adv Clin Chem, 2013,61:127-152.
|
43 |
Santen RJ,Demers L,Ohorodnik S, et al. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy[J]. Steroids, 2007,72:666-667.
|
44 |
Santen RJ,Lee JS,Wang S, et al. Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures[J]. Steroids, 2008,73:1318-1321.
|
45 |
Soldin SJ,Soldin OP. Steroid hormone analysis by tandem mass spectrometry[J]. Clin Chem, 2009,55:1061-1066.
|
46 |
Michael WO′R,Angela E,Crabtree NJ, et al. Hyperandrogenemia predicts metabolic phenotype in Polycystic Ovary Syndrome: The utility of serum androstenedione[J]. J Clin Endocr Metab, 2014,99(3):1027-1036.
|